Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Volker M Lauschke

Showing results (1-10 of 222) with videos related to

Pageof 23
Sort By:
Clinical Science (London, England : 1979)|July 22, 2017
Dysregulation of miR-223 constitutes a promising biomarker that informs about clinical outcomes of acute liver failureVolker M Lauschke
Drug Metabolism Reviews|March 8, 2021
Toxicogenomics of drug induced liver injury - from mechanistic understanding to early predictionVolker M Lauschke
Hepatobiliary Surgery and Nutrition|October 27, 2023
Practice guidance documents for the diagnosis and management of non-alcoholic fatty liver disease-recent updates and open questionsVolker M Lauschke
Arteriosclerosis, Thrombosis, and Vascular Biology|March 7, 2024
Hepatic Inhibition of ANGPTL3 Mimics the Molecular Hallmarks of HypothyroidismNayere Taebnia, Volker M Lauschke
Pharmacological Research|October 26, 2018
Genetic variability and population diversity of the human SLCO (OATP) transporter familyBoyao Zhang, Volker M Lauschke
NPJ Genomic Medicine|June 3, 2021
The prevalence, genetic complexity and population-specific founder effects of human autosomal recessive disordersQingyang Xiao, Volker M Lauschke
Clinical Pharmacology and Therapeutics|May 17, 2021
Computational Tools to Assess the Functional Consequences of Rare and Noncoding Pharmacogenetic VariabilityYitian Zhou, Volker M Lauschke
Human Genetics|November 4, 2019
The genetic landscape of the human solute carrier (SLC) transporter superfamilyLena Schaller, Volker M Lauschke
Handbook of Experimental Pharmacology|July 6, 2022
Challenges Related to the Use of Next-Generation Sequencing for the Optimization of Drug TherapyYitian Zhou, Volker M Lauschke
Journal of Pharmaceutical Sciences|July 7, 2020
The Past, Present and Future of Intestinal In Vitro Cell Systems for Drug Absorption StudiesSonia Youhanna, Volker M Lauschke
Pageof 23

Showing results (1-10 of 222) with videos related to

Sort By:
Pageof 23
Clinical Science (London, England : 1979)|July 22, 2017
Dysregulation of miR-223 constitutes a promising biomarker that informs about clinical outcomes of acute liver failureVolker M Lauschke
Drug Metabolism Reviews|March 8, 2021
Toxicogenomics of drug induced liver injury - from mechanistic understanding to early predictionVolker M Lauschke
Hepatobiliary Surgery and Nutrition|October 27, 2023
Practice guidance documents for the diagnosis and management of non-alcoholic fatty liver disease-recent updates and open questionsVolker M Lauschke
Arteriosclerosis, Thrombosis, and Vascular Biology|March 7, 2024
Hepatic Inhibition of ANGPTL3 Mimics the Molecular Hallmarks of HypothyroidismNayere Taebnia, Volker M Lauschke
Pharmacological Research|October 26, 2018
Genetic variability and population diversity of the human SLCO (OATP) transporter familyBoyao Zhang, Volker M Lauschke
NPJ Genomic Medicine|June 3, 2021
The prevalence, genetic complexity and population-specific founder effects of human autosomal recessive disordersQingyang Xiao, Volker M Lauschke
Clinical Pharmacology and Therapeutics|May 17, 2021
Computational Tools to Assess the Functional Consequences of Rare and Noncoding Pharmacogenetic VariabilityYitian Zhou, Volker M Lauschke
Human Genetics|November 4, 2019
The genetic landscape of the human solute carrier (SLC) transporter superfamilyLena Schaller, Volker M Lauschke
Handbook of Experimental Pharmacology|July 6, 2022
Challenges Related to the Use of Next-Generation Sequencing for the Optimization of Drug TherapyYitian Zhou, Volker M Lauschke
Journal of Pharmaceutical Sciences|July 7, 2020
The Past, Present and Future of Intestinal In Vitro Cell Systems for Drug Absorption StudiesSonia Youhanna, Volker M Lauschke
Pageof 23